Harmonic
HLIT
11.27
+0.05
+0.45%
Harmonic
US · HLIT
#3121 by market cap
Listed 1970
11.27
+0.05
+0.45%
Live - 5344 symbols - heartbeat 199s ago
· 2026-10-08 08:16
Pre-market
11.10
-1.51%
After-hours
11.27
0.00%
Overnight
11.18
-0.80%
- Market cap
- 1.23B
- P/E (TTM)i
- -27.49
- P/Bi
- 3.41
- EPSi
- -0.38
- Div yieldi
- 0.00%
- 52W posi
- 30%
Reader sentiment
Are you bullish or bearish on HLIT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -0.77, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -26.15% YoY
Margins
- Gross margin
- 48.47%
- Operating margin
- 4.72%
- Net margin
- -12.01%
Key ratios & quality
- Enterprise valuei
- 1.22B
- Altman Z-Scorei
- -0.77
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 403.56M | 402.87M | 378.83M | 507.15M | 624.96M | 388.48M | 488.20M | 360.52M |
| Gross profit | 209.21M | 223.01M | 195.00M | 259.74M | 315.88M | 178.12M | 240.11M | 174.75M |
| Selling & admin expenses | 118.95M | 119.04M | 119.61M | 138.09M | 146.72M | 78.27M | 79.17M | 81.38M |
| Research & development | 89.16M | 84.61M | 82.49M | 102.23M | 120.31M | 69.71M | 72.57M | 76.33M |
| Operating profit | -2.09M | 16.22M | -10.13M | 18.92M | 48.86M | 30.14M | 88.36M | 17.03M |
| Pretax profit | -16.95M | -6.60M | -26.22M | 8.87M | 44.49M | 27.85M | 71.54M | 8.86M |
| Tax | 4.09M | -672.00K | 3.05M | -4.38M | 16.30M | -60.49M | 20.82M | 7.65M |
| Net profit | -21.04M | -5.92M | -29.27M | 13.25M | 28.18M | 83.99M | 39.22M | -43.31M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Diluted EPS | -0.25 | -0.07 | -0.30 | 0.12 | 0.25 | 0.72 | 0.33 | -0.38 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 84.88M | 86.92M | 142.38M | -53.02M | 121.70M | 133.46M |
| Gross profit | 46.48M | 39.79M | 77.13M | -54.75M | 63.62M | 69.89M |
| Selling & admin expenses | 19.78M | 20.48M | 36.52M | -30.43M | 22.29M | 24.63M |
| Research & development | 19.66M | 17.99M | 29.70M | -14.16M | 20.88M | 21.20M |
| Operating profit | 7.04M | 1.31M | 10.91M | -10.16M | 20.45M | 24.06M |
| Pretax profit | 5.10M | -3.04M | 8.75M | -11.34M | 19.33M | 21.97M |
| Tax | 2.74M | -2.18M | 6.05M | -1.06M | 9.68M | 4.92M |
| Net profit | 5.94M | 2.87M | 2.69M | -54.82M | 7.31M | -2.32M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.05 | 0.03 | 0.02 | -0.49 | 0.07 | -0.02 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 196.70M | 251.36M | 238.04M | 323.13M | 345.30M | 330.73M | 565.14M | 494.37M |
| Cash & ST investments | 65.99M | 93.06M | 98.65M | 133.43M | 89.59M | 84.27M | 101.46M | 124.11M |
| Inventory | 25.64M | 29.04M | 35.03M | 71.20M | 120.95M | 83.98M | 43.06M | 47.84M |
| Total assets | 510.84M | 587.33M | 591.52M | 693.69M | 710.02M | 768.21M | 796.51M | 718.48M |
| Total current liabilities | 136.41M | 191.90M | 147.30M | 224.46M | 322.07M | 272.39M | 192.28M | 197.95M |
| Short-term debt | 7.18M | 58.97M | 19.13M | 49.16M | 125.51M | 126.59M | 7.87M | 9.38M |
| Long-term debt | 127.49M | 99.14M | 139.59M | 111.93M | 11.16M | 10.50M | 112.08M | 109.14M |
| Total liabilities | 282,585,000.00 | 332,471,000.00 | 333,221,000.00 | 396,890,000.00 | 385,512,000.00 | 331,332,000.00 | 331,248,000.00 | 335,237,000.00 |
| Total equity | 228.25M | 254.86M | 258.30M | 296.80M | 324.51M | 436.87M | 465.26M | 383.25M |
| Retained earnings | -2.07B | -2.07B | -2.10B | -2.09B | -2.05B | -1.96B | -1.95B | -2.08B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 340.69M | 342.86M | 327.03M | 494.37M | 485.26M | 417.19M |
| Cash & ST investments | 148.71M | 123.92M | 127.38M | 124.11M | 109.00M | 231.86M |
| Inventory | 62.06M | 71.14M | 68.60M | 47.84M | 51.20M | 66.47M |
| Total assets | 773.75M | 783.35M | 758.60M | 718.48M | 705.31M | 632.65M |
| Total current liabilities | 165.22M | 172.21M | 157.10M | 197.95M | 214.24M | 136.93M |
| Short-term debt | 13.23M | 14.05M | 14.66M | 9.38M | 9.36M | 8.93M |
| Long-term debt | 120.34M | 122.75M | 117.93M | 109.14M | 108.40M | 107.67M |
| Total liabilities | 327,618,000.00 | 336,945,000.00 | 315,584,000.00 | 335,237,000.00 | 350,152,000.00 | 272,299,000.00 |
| Total equity | 446.13M | 446.40M | 443.01M | 383.25M | 355.15M | 360.35M |
| Retained earnings | -1.98B | -2.00B | -2.01B | -2.08B | -2.11B | -2.11B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 12.28M | 31.30M | 39.16M | 41.02M | 5.48M | 7.06M | 61.92M | 107.97M |
| Depreciation & amortization | 21.34M | 19.61M | 15.71M | 13.05M | 12.26M | 12.26M | 12.14M | 11.08M |
| Free cash flow | 5.24M | 20.97M | 6.96M | 28.04M | -3.77M | -1.42M | 52.73M | 96.89M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 4.95M | 8.41M | 5.47M | 12.31M | 1.96M | 6.56M | -23.42M | -73.04M |
| Ending cash balance | 65.99M | 93.06M | 98.65M | 133.43M | 89.59M | 84.27M | 101.79M | 124.46M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 83.61M | -11.70M | 23.77M | 12.29M | 31.69M | -5.43M |
| Depreciation & amortization | 2.72M | 2.67M | 2.82M | 2.87M | 2.52M | 2.67M |
| Free cash flow | 81.73M | -15.50M | 21.04M | 9.61M | 30.29M | -7.04M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -33.02M | -14.02M | -12.73M | -13.27M | -39.86M | 1.45M |
| Ending cash balance | 149.04M | 124.27M | 127.72M | 124.46M | 109.37M | 232.24M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -9.42 | -2.45 | -11.41 | 4.78 | 9.07 | 22.06 | 8.69 | -10.21 |
| ROA %i | -4.13 | -1.08 | -4.97 | 2.06 | 4.02 | 11.36 | 5.01 | -5.72 |
| ROIC %i | -3.57 | 1.14 | -4.73 | 4.52 | 6.45 | 15.98 | 7.33 | -7.13 |
| 5-year avg ROE %i | -16.53 | -14.89 | -16.27 | -10.49 | -1.89 | 4.41 | 6.64 | 6.88 |
| EBIT margin %i | -1.37 | 1.25 | -3.88 | 3.84 | 7.92 | 3.59 | 9.62 | 3.51 |
| FCF / sales %i | 1.30 | 5.20 | 1.84 | 5.53 | -- | -- | 7.77 | 26.87 |
| Current ratioi | 1.44 | 1.31 | 1.62 | 1.44 | 1.07 | 1.21 | 2.94 | 2.50 |
| Quick ratioi | 1.17 | 1.02 | 1.19 | 1.02 | 0.63 | 0.85 | 1.28 | 1.07 |
| Debt / assetsi | 26.36 | 31.31 | 31.24 | 27.42 | 22.64 | 20.31 | 16.91 | 18.54 |
| LT debt / equityi | 55.86 | 49.01 | 64.14 | 47.52 | 10.87 | 6.74 | 27.26 | 32.30 |
| Interest coveragei | -0.49 | 0.43 | -1.28 | 1.83 | 9.83 | 8.10 | 8.91 | 3.33 |
| Revenue CAGR (3Y) %i | 2.29 | -0.25 | 1.88 | 7.91 | 15.76 | 0.84 | -1.26 | -16.75 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | 43.56 | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | 74.91 | -- | -- | 23.43 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 12.45 | 16.36 | 11.38 | -10.21 | -10.47 | -11.69 |
| ROA %i | 7.03 | 9.17 | 6.54 | -5.72 | -5.67 | -6.66 |
| ROIC %i | 10.16 | 13.02 | 9.20 | -7.13 | -7.37 | -8.27 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.33 | 15.13 | 13.01 | 3.51 | 6.70 | 11.64 |
| FCF / sales %i | 15.88 | 17.15 | 20.99 | 26.87 | 11.44 | 12.14 |
| Current ratioi | 2.06 | 1.99 | 2.08 | 2.50 | 2.26 | 3.05 |
| Quick ratioi | 1.53 | 1.44 | 1.50 | 1.07 | 0.91 | 2.36 |
| Debt / assetsi | 19.20 | 19.27 | 19.32 | 18.54 | 18.58 | 20.57 |
| LT debt / equityi | 30.34 | 30.67 | 29.77 | 32.30 | 34.27 | 33.63 |
| Interest coveragei | 10.53 | 13.19 | 12.92 | 3.33 | 7.52 | 14.51 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Product sales is the largest reported line at 77.99% of revenue, across 3 reported segments.
- The next-largest line, Software as a Service (SaaS) and services, is a distant second at 12.32% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Product sales77.99%
Software as a Service (SaaS) and services12.32%
Professional services9.68%
Quote time 2026-10-08 08:16:39 · For reference only, not investment advice and not tailored to your situation.